申请人:Obsidian Therapeutics, Inc.
公开号:US20190192691A1
公开(公告)日:2019-06-27
The present invention provides regulatable biocircuit systems. Such systems provide modular and tunable protein expression systems in support of the discovery and development of therapeutic modalities.